Stephen Oh
Co-Chief-Division of Hematology · Washington University/B-JH/SLCH Consortium
Credentials: · · · · ·
History
- Present
Hematology Division · Washington University/B-JH/SLCH Consortium
- 2007–2008
Hematology
2004–2007
2000–2004
Research
Science Translational Medicine · 2016 · 796 citations
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
New England Journal of Medicine · 2016 · 716 citations
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML
New England Journal of Medicine · 2013 · 454 citations
35 papers
24 papers
22 papers
- SV
22 papers
16 papers
15 papers · 4 as a resident
13 papers
- MT
13 papers
Grants
- 2026–2031
National Heart, Lung, and Blood Institute · P01
Contact PI · $2.4M · Washington University
- 1975–2031
Pre-and Postgraduate Training in Molecular Hematology
National Heart, Lung, and Blood Institute · T32
Contact PI · $3.5M · Washington University
- 2017–2027
Dysregulated NFkB Pathway Signaling In Myeloproliferative Neoplasms
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.9M · Washington University
- 2021–2024
National Cancer Institute · UH2
Contact PI · $720.6K · Washington University
Clinical trials
- 2018–2021
Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis
Principal investigator · Terminated · Phase 1
Washington University School of Medicine
- 2009–2012
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Principal investigator · Terminated
Stanford University